Insights

Strategic Partnerships Calithera is a clinical-stage biopharma with a pipeline of targeted oncology therapies and a history of partnerships and asset in-licensing, including Takeda assets and collaboration with Antengene. Potential sales opportunity: target collaboration discussions around in-licensing or co-development of biomarker-defined cancer therapies and access to their clinical pipeline.

Commercial Leadership Recent leadership changes and a dedicated Senior VP of Commercial and Portfolio Strategy suggest a focus on building commercial pathways for first-in-class oral therapeutics. Potential sales opportunity: engage in early dialogue on market access, pricing strategies, and physician adoption plans to support upcoming launches.

Funding & Growth Financials show moderate revenue and substantial funding, indicating runway for continued R&D and potential partner-driven monetization. Potential sales opportunity: propose solutions for regional commercialization support, contract development and manufacturing, or analytics services to accelerate portfolio value.

Technology Enablement Tech stack includes cloud platforms (AWS, Google Cloud), content and CRM systems (WordPress, Drupal, Shopify, Microsoft Dynamics) and observability (New Relic), signaling a modern digital footprint that can integrate with external tools. Potential sales opportunity: offer scalable cloud-based data integration, analytics, and digital engagement solutions to support clinical operations and partner ecosystems.

Market Positioning Calithera focuses on biomarker-defined, metabolism-targeting cancer therapies with collaborations across biotech and pharma, positioning for niche but high-value opportunities in oncology. Potential sales opportunity: identify co-promotional or regional licensing opportunities, and provide market access intelligence and payer strategy support to navigate specialty oncology segments.

Similar companies to Calithera Biosciences

Calithera Biosciences Tech Stack

Calithera Biosciences uses 8 technology products and services including Amazon Web Services, Drupal, WordPress, and more. Explore Calithera Biosciences's tech stack below.

Media & News

Calithera Biosciences's Email Address Formats

Calithera Biosciences uses at least 4 email formats:
Calithera Biosciences Email FormatsExamplePercentage
FLast@calithera.comJDoe@calithera.com
88%
First.Last@calithera.comJohn.Doe@calithera.com
8%
Last@calithera.comDoe@calithera.com
3%
FirstLast@calithera.comJohnDoe@calithera.com
1%

Frequently Asked Questions

What is Calithera Biosciences's phone number?

Minus sign iconPlus sign icon
You can contact Calithera Biosciences's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Calithera Biosciences's stock symbol?

Minus sign iconPlus sign icon
Calithera Biosciences is a publicly traded company; the company's stock symbol is CALA.

What is Calithera Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Calithera Biosciences's official website is calithera.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Calithera Biosciences generate?

Minus sign iconPlus sign icon
As of October 2026, Calithera Biosciences's annual revenue is estimated to be $25M - $50M.

What is Calithera Biosciences's SIC code and NAICS code?

Minus sign iconPlus sign icon
Calithera Biosciences's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Calithera Biosciences have currently?

Minus sign iconPlus sign icon
As of October 2026, Calithera Biosciences has approximately 25 employees across 2 continents, including North America and Europe. Key team members include Chief Business Officer: S. H., Owner: J. C. and Senior Vice President, Drug Discovery: A. S. Explore Calithera Biosciences's employee directory with LeadIQ.

What industry does Calithera Biosciences belong to?

Minus sign iconPlus sign icon
Calithera Biosciences operates in the Pharmaceutical Manufacturing industry.

What technology does Calithera Biosciences use?

Minus sign iconPlus sign icon
Calithera Biosciences's tech stack includes Amazon Web Services, Drupal, WordPress, Shopify, Microsoft Dynamics, Google Cloud, WP Engine and New Relic.

What is Calithera Biosciences's email format?

Minus sign iconPlus sign icon
Calithera Biosciences's email format typically follows the pattern of FLast@calithera.com. Find more Calithera Biosciences email formats with LeadIQ.

How much funding has Calithera Biosciences raised to date?

Minus sign iconPlus sign icon
As of October 2026, Calithera Biosciences has raised $341M in funding. The last funding round occurred on Mar 30, 2022 for $10M.

When was Calithera Biosciences founded?

Minus sign iconPlus sign icon
Calithera Biosciences was founded in 2010.
Calithera Biosciences logo

Calithera Biosciences

Pharmaceutical ManufacturingCalifornia, United States11-50 Employees

Calithera Biosciences is a clinical-stage biopharmaceutical company focused on oncology, developing targeted therapies that disrupt cellular metabolic pathways to preferentially starve tumor cells and boost immune-cell activity. It pursues an oral therapeutics pipeline aimed at broadening treatment options for cancer and other life-threatening diseases. The company is based in South San Francisco, California, and employs between 11 and 50 people. It operates within the pharmaceutical and biopharmaceutical landscape and has pursued partnerships and asset acquisitions to advance its pipeline. Publicly available figures note revenue in the 25–50 million range and about 10 million in funding, though these figures are not central to the company overview.

Section iconCompany Overview

Phone number
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
CALA
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2010
Employees
11-50

Section iconFunding & Financials

  • $341M

    Calithera Biosciences has raised a total of $341M of funding over 12 rounds. Their latest funding round was raised on Mar 30, 2022 in the amount of $10M as a Post IPO Equity.

  • $25M - $50M

    Calithera Biosciences's revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.